Idexx Laboratories (IDXX) Short term Debt (2009 - 2026)

Idexx Laboratories' Short term Debt history runs 18 years deep, the most recent figure standing at $530.0 million for Q1 2026.

• In Q1 2026, Short term Debt rose 210.07% year-over-year to $530.0 million; the TTM figure through Mar 2026 stood at $530.0 million (up 210.07% YoY), while the FY2025 annual figure was $75.0 million, down 70.0% from the prior year.
• Short term Debt was $530.0 million for Q1 2026 at Idexx Laboratories, up from $75.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $633.0 million in Q3 2022 to a low of $75.0 million in Q4 2025.
• Historically, Short term Debt has averaged $299.9 million across 5 years, with a median of $250.0 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Short term Debt soared 744.11% in 2022, then sank 76.3% in 2023.
• A 5-year view of Short term Debt shows it stood at $250.0 million in 2022, then slumped by 70.0% to $75.0 million in 2023, then surged by 233.35% to $250.0 million in 2024, then sank by 70.0% to $75.0 million in 2025, then surged by 606.71% to $530.0 million in 2026.
• The last three Short term Debt figures came in at $530.0 million (Q1 2026), $75.0 million (Q4 2025), and $455.0 million (Q3 2025), per Business Quant data.